About Bailey Kirkpatrick
Bailey Kirkpatrick is a science writer with a background in epigenetics and psychology with a passion for conveying scientific concepts to the wider community. She enjoys speculating about the implications of epigenetics and how it might impact our perception of wellbeing and the development of novel preventative strategies. When she’s not combing through research articles, she also enjoys discovering new foods, taking nighttime strolls, and discussing current events over a barrel-aged sour beer or cold-brewed coffee.

Scientists at Epigentek Develop Revolutionary Kit to Validate Antibodies for ChIP

July 14, 2014 Bailey Kirkpatrick

Every epigenetics scientist knows that chromatin immunoprecipitation (ChIP) is a valuable technique for studying protein-DNA interactions.  They also know that antibodies used in ChIP to capture the DNA/protein complex must be reliable and specifically recognize the fixed protein that is bound to the chromatin complex. But how can a researcher be certain that the antibodies they are using work well in ChIP?  For many researchers it is not always the case to be “blessed” with a quality ChIP-grade antibody and, unfortunately, [more…]

Delivery by Cesaerian Section Linked to Epigenetic Changes in Infant’s Blood Stem Cells

July 9, 2014 Bailey Kirkpatrick

The way a baby is delivered may epigenetically impact stem cells of the infant, according to a new study at Karolinska Institutet. Their findings could help scientists understand the differences between various modes of delivery, for example, why babies delivered via cesarean section are statistically more susceptible to immunological diseases. It’s still uncertain whether this epigenetic mechanism is long-term or temporary. Women are now more than ever electing to give birth by cesarean section, the most popular surgical procedure in [more…]

Epigenetic Signature Found in Blood Predicts Chances of Getting Breast Cancer

July 2, 2014 Bailey Kirkpatrick

If a woman could get a blood test telling her whether or not she’s likely to develop breast cancer, preventative measures could be taken, doctors could monitor her health, and she could explore potential options even before the cancer has started. A blood test like this could be possible as a result of new research by University College London (UCL) scientists, led by Professor Martin Widschwendter, head of the UCL Department of Women’s Cancer. The research team, whose study was [more…]

Quick Tips for Validating Antibodies for Chromatin Immunoprecipitation (ChIP)

June 26, 2014 Bailey Kirkpatrick

Researchers rely on high quality antibodies to perform successful chromatin immunoprecipitation (ChIP) experiments. When investigating the protein-DNA interaction of interest, valid and reliable results simply cannot be attained using nonspecific and inefficient antibodies. If the antibody doesn’t come “ChIP-qualified” or “ChIP-grade” from the supplier, there are several tips you can follow to determine if it’s likely to perform well in ChIP and won’t pull down distracting material to get in the way of a successful study. Carry out the standard [more…]

Dad’s Drinking Could Epigenetically Affect Son’s Sensitivity and Preference for Alcohol

June 18, 2014 Bailey Kirkpatrick

According to a new study from University of Pittsburgh School of Medicine, a father’s excessive drinking behavior could set up his son for , even before conception. Results published in PLOS ONE demonstrate that mice show more sensitivity to alcohol’s effects and are less likely to drink it if their fathers were chronically exposed to the substance before mating. This recent animal study adds to the evidence linking heredity and the propensity for alcohol abuse. Previous studies support the inheritance of [more…]

Epigenetic Change Tied to Hardening of the Arteries

June 11, 2014 Bailey Kirkpatrick

New research suggests that when patterns of blood flow are disturbed, epigenetic changes occur to the genes in the cells lining blood vessels, contributing to hardening of the arteries, otherwise known as atherosclerosis. Characterized by the accumulation of inflammatory cells and fats in arteries, this disease often precedes strokes and heart attacks. Blood flow and the natural curves of the arteries are known to dictate where atherosclerotic plaques develop. Along with his colleagues, Hanjoong Jo, a biomedical engineer and professor [more…]

Do We Already Have A Drug That Could Epigenetically Erase Traumatic Memories?

June 4, 2014 Bailey Kirkpatrick

Scientists at the Virginia Commonwealth University School of Medicine discovered that the drug fingolimod, which is used to treat multiple sclerosis (MS), could potentially benefit individuals who wish to get rid of painful and traumatic memories. While MS is still not entirely understood, the disease involves a process that is immune-mediated in which the immune system attacks healthy parts of the body, namely the central nervous system – the spinal cord, brain, and optic nerves. Fingolimod, or FTY720, is a [more…]

Scientists Solve 30 Year Old Breast Cancer Riddle

May 28, 2014 Bailey Kirkpatrick

Scientists at the Fred Hutchinson Cancer Research Center found that mice lacking one copy of a gene called CTCF have abnormal DNA methylation and are markedly predisposed to cancer. This ground-breaking research helps solve a mystery that has loomed for over 30 years – which gene or genes cause the frequent loss of one copy of chromosome 16  in breast cancer cells. Dr. Gala Flippova, staff scientist at Fred Hutchinson, and his colleagues originally cloned the CTCF gene and mapped [more…]

Computer Algorithm Uses Epigenetics to Identify “Aging Genes”

May 21, 2014 Bailey Kirkpatrick

Restricting calorie consumption without malnutrition has been shown to prolong lifespan in various species, including yeast, worms, flies, monkeys, and humans. Although the underlying mechanism is not yet known, an advanced computer algorithm sheds light on the concept and potential causes. At Tel Aviv University’s Blavatnik School of Computer Science, Keren Yizhak and her colleagues developed something called a genome-scale metabolic model (GSMM), creating a computer algorithm that predicts which genes can be “turned off” to produce the same anti-aging [more…]

Epigenetics Holds the Answer to Chemoresistance in Ovarian Cancer Patients

May 14, 2014 Bailey Kirkpatrick

A study conducted at Georgia State University and the University of Georgia gives us novel insight into the chemoresistance of ovarian cancer and offers a potential therapeutic approach to overcoming it. Inhibiting enzymes that lead to changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers say. Dr. Susanna Greer and her colleagues have identified two enzymes that suppress proteins that regulate cell survival and chemoresistance in ovarian cancer. Ovarian cancer is the deadliest of all gynecologic [more…]

1 14 15 16 17

WIE-logo-icon

If you like reading our articles…

Join our e-newsletter! Stay up-to-date with our weekly posts on epigenetics and health, nutrition, exercise, and more.